Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Apolipoprotein B-100, Familial Defective

quinazolines has been researched along with Apolipoprotein B-100, Familial Defective in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leren, TP1

Other Studies

1 other study(ies) available for quinazolines and Apolipoprotein B-100, Familial Defective

ArticleYear
Doxazosin increases low density lipoprotein receptor activity.
    Acta pharmacologica et toxicologica, 1985, Volume: 56, Issue:3

    Topics: Adrenergic alpha-Antagonists; Cell Line; Cells, Cultured; Child, Preschool; Doxazosin; Fibroblasts; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Prazosin; Quinazolines; Receptors, Cell Surface; Receptors, Lipoprotein

1985